Time Course Profile of Adverse Events of Interest and Serious Adverse Events With Darolutamide in the ARAMIS Trial

被引：0

作者：

Grabbert, Markus ^{[1
]}

Gratzke, Christian ^{[1
]}

Fizazi, Karim ^{[2
]}

Shore, Neal ^{[3
]}

Smith, Matthew ^{[4
]}

Feyerabend, Susan ^{[5
]}

Carles, Joan ^{[6
]}

Lebret, Thierry ^{[7
]}

Vjaters, Egils ^{[8
]}

Werbrouck, Patrick ^{[9
]}

Miskic, Marina ^{[10
]}

Schmall, Anja ^{[11
]}

Le Berre, Marie Aude ^{[12
]}

Borghesi, Gustavo ^{[13
]}

Verholen, Frank ^{[14
]}

机构：

[1] Univ Hosp Freiburg, Freiburg, Germany

[2] Univ Paris Saclay, Inst Gustave Roussy, Villejuif, France

[3] Carolina Urol Res Ctr, Myrtle Beach, SC USA

[4] Massachusetts Gen Hosp, Boston, MA USA

[5] Studienpraxis Urol, Nuertingen, Germany

[6] Hosp Univ Vall dHebron, Vall dHebron Inst Oncol, Barcelona, Spain

[7] Hop Foch, Suresnes, France

[8] P Stradins Clin Univ Hosp, Riga, Latvia

[9] AZ Groeninge, Kortrijk, Belgium

[10] Bayer Consumer Care AG, Basel, Switzerland

[11] Bayer Vital GmbH, Leverkusen, Germany

[12] Bayer Healthcare SAS, Loos, France

[13] Bayer AG, Berlin, Germany

[14] Bayer Healthcare SAS, Basel, Switzerland

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 3期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

327

引用

页码：105 / 105

页数：1

共 50 条

[21] Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS
Shore, Neal D.
Gratzke, Christian
Feyerabend, Susan
Werbrouck, Patrick
Carles, Joan
Vjaters, Egils
Tammela, Teuvo L. J.
Morris, David
Aragon-Ching, Jeanny B.
Concepcion, Raoul S.
Emmenegger, Urban
Fleshner, Neil
Grabbert, Markus
Lietuvietis, Vilnis
Mahammedi, Hakim
Cruz, Felipe M.
Paula, Adriano
Pieczonka, Christopher
Rannikko, Antti
Richardet, Martin
Silveira, Glauco
Kuss, Iris
Le Berre, Marie-Aude
Verholen, Frank
Sarapohja, Toni
Smith, Matthew R.
Fizazi, Karim
ONCOLOGIST, 2024, 29 (07): : 581 - 588
[22] The Association of Age and Pulse Pressure to Serious Adverse Events in the SPRINT Trial
Krishnaswami, Ashok
Kim, Dae H.
Forman, Daniel E.
Maurer, Matthew S.
Alexander, Karen P.
Rich, Michael W.
CIRCULATION, 2017, 136
[23] Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile
Budikayanti, Astri
Qadri, Lubna Muhammad
Syeban, Zakiah
Indrawati, Luh Ari
Octaviana, Fitri
NEUROLOGY RESEARCH INTERNATIONAL, 2018, 2018
[24] Serious adverse events in the transition period of the newborn
Mena N, Patricia
Novoa P, Jose Manuel
Cortes C, Juan Pablo
REVISTA CHILENA DE PEDIATRIA-CHILE, 2013, 84 (02): : 177 - 181
[25] Human albumin: serious adverse events rare
Reactions Weekly, 2003, 980 (1) : 4 - 4
[26] Isotretinoin (Accutane) and serious psychiatric adverse events
O'Connell, KA
Wilkin, JK
Pitts, M
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 48 (02) : 306 - 308
[27] No association of HPV vaccination with serious adverse events
Caskey, Rachel
JOURNAL OF PEDIATRICS, 2014, 164 (05): : 1240 - 1240
[28] Identification of serious, unpredictable adverse events with tocilizumab
Reactions Weekly, 2020, 1813 (1) : 6 - 6
[29] Serious adverse events and the Modafinil Augmentation Study
Block, J
CNS SPECTRUMS, 2006, 11 (05) : 340 - 340
[30] Postoperative serious adverse events in a teaching hospital
Tracy, GD
MEDICAL JOURNAL OF AUSTRALIA, 2002, 177 (05) : 276 - 276

← 1 2 3 4 5 →